Item 5. Other Information

a.None

b.None

c.Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements by Our Directors and Officers

During the quarterly period covered by this report, our directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted, terminated or modified the Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K) set forth in the table below. No non-Rule 10b5-1 trading arrangements were adopted, modified or terminated by any director or officer during the quarterly period covered by this report.


Name			Title			Type of Trading Arrangement			Security			Action			Date of Action			Duration of Trading Arrangement			Aggregate Number of Securities Covered
Karthik Kuppusamy			SVP, Clinical Solutions			Rule 10b5-1 plan to sell			Common Stock			Adoption			February 26, 2026			February 26, 2026 to February 26, 2027*			Up to 8,147*

Includes shares of common stock to be released from stock options.

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits